Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析

◆英語タイトル:Dawnrays Pharmaceutical (Holdings) Ltd (2348) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82012FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude and cefotaxime acid, among others. Dawnrays also provides cephalosporin antibiotic intermediates, bulk medicines and powder for injections for therapeutic areas such as anti-allergic, digestive system, cardiovascular system and urinary system and endocrine system, among others and its research and development activities are concentrated on generic drugs of system specific medicines. The company markets its products in Hong Kong and abroad. Dawnrays is headquartered in Hong Kong.

Dawnrays Pharmaceutical (Holdings) Ltd Key Recent Developments

Mar 27,2021: Dawnrays Pharmaceutical announces Annual Results for the year ended 31 December 2020

This comprehensive SWOT profile of Dawnrays Pharmaceutical (Holdings) Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Dawnrays Pharmaceutical (Holdings) Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Dawnrays Pharmaceutical (Holdings) Ltd – Key Information
Dawnrays Pharmaceutical (Holdings) Ltd – Overview
Dawnrays Pharmaceutical (Holdings) Ltd – Key Employees
Dawnrays Pharmaceutical (Holdings) Ltd – Key Employee Biographies
Dawnrays Pharmaceutical (Holdings) Ltd – Key Operational Heads
Dawnrays Pharmaceutical (Holdings) Ltd – Major Products and Services
Dawnrays Pharmaceutical (Holdings) Ltd – History
Dawnrays Pharmaceutical (Holdings) Ltd – Company Statement
Dawnrays Pharmaceutical (Holdings) Ltd – Locations And Subsidiaries
Dawnrays Pharmaceutical (Holdings) Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Dawnrays Pharmaceutical (Holdings) Ltd – Business Description
Dawnrays Pharmaceutical (Holdings) Ltd – Corporate Strategy
Dawnrays Pharmaceutical (Holdings) Ltd – SWOT Analysis
SWOT Analysis – Overview
Dawnrays Pharmaceutical (Holdings) Ltd – Strengths
Dawnrays Pharmaceutical (Holdings) Ltd – Weaknesses
Dawnrays Pharmaceutical (Holdings) Ltd – Opportunities
Dawnrays Pharmaceutical (Holdings) Ltd – Threats
Dawnrays Pharmaceutical (Holdings) Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Dawnrays Pharmaceutical (Holdings) Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Dawnrays Pharmaceutical (Holdings) Ltd, Key Information
Dawnrays Pharmaceutical (Holdings) Ltd, Key Ratios
Dawnrays Pharmaceutical (Holdings) Ltd, Share Data
Dawnrays Pharmaceutical (Holdings) Ltd, Major Products and Services
Dawnrays Pharmaceutical (Holdings) Ltd, History
Dawnrays Pharmaceutical (Holdings) Ltd, Key Employees
Dawnrays Pharmaceutical (Holdings) Ltd, Key Employee Biographies
Dawnrays Pharmaceutical (Holdings) Ltd, Key Operational Heads
Dawnrays Pharmaceutical (Holdings) Ltd, Other Locations
Dawnrays Pharmaceutical (Holdings) Ltd, Subsidiaries
Dawnrays Pharmaceutical (Holdings) Ltd, Key Competitors
Dawnrays Pharmaceutical (Holdings) Ltd, SWOT Analysis
Dawnrays Pharmaceutical (Holdings) Ltd, Ratios based on current share price
Dawnrays Pharmaceutical (Holdings) Ltd, Annual Ratios
Dawnrays Pharmaceutical (Holdings) Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Campbell Soup Company (CPB):企業の財務・戦略的SWOT分析
    Campbell Soup Company (CPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • NRG Energy Inc (NRG):企業の財務・戦略的SWOT分析
    NRG Energy Inc (NRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Australian Broadcasting Corp:企業の戦略的SWOT分析
    Australian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Browns Brasserie and Bar:企業の戦略・SWOT・財務情報
    Browns Brasserie and Bar - Strategy, SWOT and Corporate Finance Report Summary Browns Brasserie and Bar - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BYD Company Limited:企業の戦略・SWOT・財務分析
    BYD Company Limited - Strategy, SWOT and Corporate Finance Report Summary BYD Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gordon Ramsay Holdings Limited:企業の戦略・SWOT・財務情報
    Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Gordon Ramsay Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sujana Universal Industries Ltd. (SUJANAUNI):企業の財務・戦略的SWOT分析
    Sujana Universal Industries Ltd. (SUJANAUNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Promius Pharma LLC-製薬・医療分野:企業M&A・提携分析
    Summary Promius Pharma LLC (Promius Pharma) a subsidiary of Dr. Reddy's Laboratories Ltd is a provider of dermatology and neurology products. The company’s products include clocortolone pivalate, promiseb topical cream, coal tar, betamethasone dipropionate, triamcinolone acetonide ointment, USP, su …
  • Evotec AG (EVT):製薬・医療:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Yanlord Land Group Ltd:戦略・SWOT・企業財務分析
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ATGen Co Ltd (182400):製薬・医療:M&Aディール及び事業提携情報
    Summary ATGen Co Ltd (ATGen) is a manufacturer and supplier of proteins and monoclonal antibodies. The company offers neuroproteins, enzymes, heat shock proteins, ubiquitins, cancer related proteins, antibodies, viral antigens and hormones. It conducts research and development of medicines based on …
  • Aratana Therapeutics Inc (PETX):企業の財務・戦略的SWOT分析
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • SGS SA (SGSN):企業の財務・戦略的SWOT分析
    SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Illumina Inc (ILMN)-医療機器分野:企業M&A・提携分析
    Summary Illumina, Inc. (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; micro …
  • Tethys Petroleum Ltd (TPL.H):企業の財務・戦略的SWOT分析
    Tethys Petroleum Ltd (TPL.H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Viking Line ABP:企業の戦略・SWOT・財務情報
    Viking Line ABP - Strategy, SWOT and Corporate Finance Report Summary Viking Line ABP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Helius Medical Technologies Inc (HSM):製品パイプライン分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that offers neurological wellness solutions. The company offers development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It offers development of technolog …
  • Cub Energy Inc (KUB):石油・ガス:M&Aディール及び事業提携情報
    Summary Cub Energy Inc (Cub Energy), formerly 3P International Energy Corp is an oil and gas company that explores and develops oil and gas assets in Ukraine. The company operates its oil and gas exploration assets in Transcarpathian Basin and Dnieper-Donets Basin. It uses technologies such as fract …
  • Achillion Pharmaceuticals Inc:企業の戦略的SWOT分析
    Achillion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Stora Enso Oyj (STERV):企業の財務・戦略的SWOT分析
    Stora Enso Oyj (STERV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆